Other OTC - Delayed Quote USD

Rapid Dose Therapeutics Corp. (RDTCF)

0.0151 0.0000 (0.00%)
At close: March 27 at 1:12 PM EDT
Key Events
Advanced Chart
Loading Chart for RDTCF
DELL
  • Previous Close 0.0151
  • Open 0.0151
  • Bid --
  • Ask --
  • Day's Range 0.0151 - 0.0151
  • 52 Week Range 0.0021 - 0.2932
  • Volume 200
  • Avg. Volume 12,151
  • Market Cap (intraday) 19.137M
  • Beta (5Y Monthly) 0.71
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date Apr 29, 2024 - May 3, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active molecule into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.

rapid-dose.com

--

Full Time Employees

February 28

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Rapid Dose Therapeutics Corp.

Recent News: RDTCF

View More
View More

Performance Overview: RDTCF

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RDTCF
0.00%
S&P/TSX Composite index
4.82%

1-Year Return

RDTCF
619.05%
S&P/TSX Composite index
7.48%

3-Year Return

RDTCF
90.16%
S&P/TSX Composite index
15.01%

5-Year Return

RDTCF
--
S&P/TSX Composite index
31.60%

Compare To: RDTCF

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

RDTCF
Rapid Dose Therapeutics Corp.
0.0151
0.00%
Mkt Cap 19.137M
Industry Biotechnology
IGXT
IntelGenx Technologies Corp.
0.1640
-1.61%
Mkt Cap 28.637M
Industry Biotechnology

Statistics: RDTCF

View More

Valuation Measures

Annual
As of 4/26/2024

  • Market Cap

    19.52M

  • Enterprise Value

    21.41M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.06

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    20.49

  • Enterprise Value/EBITDA

    -9.17

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -80.78%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.05M

  • Net Income Avi to Common (ttm)

    -3.56M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    166.18k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    86.13k

View More

Company Insights: RDTCF

People Also Watch

SRBCF Sirona Biochem Corp.
0.0520
0.00%
 
AJIA Ajia Innogroup Holdings, Ltd.
0.0001
0.00%
 
MBXBF Microbix Biosystems Inc.
0.2450
-2.00%
 
CRPOF Ceapro Inc.
0.1845
0.00%
 
CUBT Curative Biotechnology, Inc.
0.0280
+11.11%
 
ATCMF Atico Mining Corporation
0.1403
-6.47%
 
ASGOF Asante Gold Corporation
0.8500
0.00%
 
EMMA Emmaus Life Sciences, Inc.
0.1000
0.00%
 
CLGPF Clean Seed Capital Group Ltd.
0.1500
0.00%
 
TMNA Agri-Fintech Holdings, Inc.
0.0001
0.00%
 
VEXTF Vext Science, Inc.
0.1757
+3.35%
 
OCGSF Outcrop Silver & Gold Corporation
0.1640
+4.99%
 
VPHIF Valeo Pharma Inc.
0.1050
0.00%
 
TBBA TEB Bancorp, Inc
6.30
+1.61%
 
AUCUF Inflection Resources Ltd.
0.1482
+5.86%
 
BIOAF Bioasis Technologies Inc.
0.0040
0.00%